Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Background: Estimating distant recurrence (DR) risk among women with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2 (HER2)–negative early breast cancer helps decisions on using adjuvant chemotherapy. The 21-gene Oncotype DX recurrence score (RS) is widely used for this. E...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Natl Cancer Inst
Главные авторы: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Denkert, Carsten, Dubsky, Peter, Krappmann, Kristin, Scheer, Marsel, Petry, Christoph, Cuzick, Jack, Dowsett, Mitch
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2016
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241904/
https://ncbi.nlm.nih.gov/pubmed/27400969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw149
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы